EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

System-Wide, Electronic Health Record–Based Medication Alerts for Appropriate Prescribing of Direct Oral Anticoagulants: Pilot Randomized Controlled Trial

Shawna N Smith iD, Michael S M Lanham iD, F Jacob Seagull iD, Morris Fabbri iD, Michael P Dorsch iD, Kathleen Jennings, Geoffrey Barnes iD

JMIR Formative Research · 2024

DOI: 10.2196/64674 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Formative Research, 2024. Verfasst von Shawna N Smith und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, United States. Hauptthemen laut MEDLINE: Electronic Health Records, Anticoagulants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While direct oral anticoagulants (DOACs) have improved oral anticoagulation management, inappropriate prescribing remains prevalent and leads to adverse drug events. Antithrombotic stewardship programs seek to enhance DOAC prescribing but require scalable and sustainable strategies.

Objective

We present a pilot, prescriber-level randomized controlled trial to assess the effectiveness of electronic health record (EHR)–based medication alerts in a large health system.

Methods

The pilot assessed prescriber responses to alerts for initial DOAC prescription errors (apixaban and rivaroxaban). A user-centered, multistage design process informed alert development, emphasizing clear indication, appropriate dosing based on renal function, and drug-drug interactions. Alerts appeared whenever a DOAC was being prescribed in a way that did not follow package label instructions. Clinician responses measured acceptability, accuracy, feasibility, and utilization of the alerts.

Results

The study ran from August 1, 2022, through April 30, 2023. Only 1 prescriber requested trial exclusion, demonstrating acceptability. The error rate for false alerts due to incomplete data was 6.6% (16/243). Two scenarios with alert design and/or execution errors occurred but were quickly identified and resolved, underlining the importance of a responsive quality assurance process in EHR-based interventions. Trial feasibility issues related to alert-data capture were identified and resolved. Trial feasibility was also assessed with balanced randomization of prescribers and the inclusion of various alerts across both medications. Assessing utilization, 34.2% (83/243) of the encounters (with 134 prescribers) led to a prescription change.

Conclusions

The pilot implementation study demonstrated the acceptability, accuracy, feasibility, and estimates of the utilization of EHR-based medication alerts for DOAC prescriptions and successfully established just-in-time randomization of prescribing clinicians. This pilot study sets the stage for large-scale, randomized implementation evaluations of EHR-based alerts to improve medication safety. Trial Registration ClinicalTrials.gov NCT05351749; https://clinicaltrials.gov/study/NCT05351749

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Health RecordsAnticoagulantsHumansPilot ProjectsMaleMedication ErrorsAdministration, OralFemaleMedical Order Entry SystemsRivaroxabanPyridonesPyrazoles

Stichwörter der Autor:innen

EHRRCTalert system optimizationclinical decision supportdirect oral anticoagulantselectronic health recordmedication safetyoral anticoagulantspilot randomized controlled trialprescribing errorsrandomized controlled trial

Substanzen

AnticoagulantsapixabanRivaroxabanPyridonesPyrazoles

Autor:innen und Institutionen

  • Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, United States.
  • Michigan Program on Value Enhancement, Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States.
  • Department of Learning Health Sciences, University of Michigan, Ann Arbor, MI, United States.
  • Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, United States.
  • College of Pharmacy, University of Michigan, Ann Arbor, MI, United States.
  • Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, MI, United States.

ORCID-Profile: Shawna N Smith, Michael S M Lanham, F Jacob Seagull, Morris Fabbri, Michael P Dorsch, Geoffrey Barnes

Förderung

  • AHRQ HHS

Zitieren

APA

Smith, S. N., Lanham, M. S. M., Seagull, F. J., Fabbri, M., Dorsch, M. P., Jennings, K., & Barnes, G. (2024). System-Wide, Electronic Health Record–Based Medication Alerts for Appropriate Prescribing of Direct Oral Anticoagulants: Pilot Randomized Controlled Trial. JMIR Formative Research. https://doi.org/10.2196/64674

Vancouver

Smith SN, Lanham MSM, Seagull FJ, Fabbri M, Dorsch MP, Jennings K, et al. System-Wide, Electronic Health Record–Based Medication Alerts for Appropriate Prescribing of Direct Oral Anticoagulants: Pilot Randomized Controlled Trial. JMIR Formative Research. 2024. doi:10.2196/64674

BibTeX
@article{Smith2024,
  author = {Smith, Shawna N and Lanham, Michael S M and Seagull, F Jacob and Fabbri, Morris and Dorsch, Michael P and Jennings, Kathleen and Barnes, Geoffrey},
  title = {System-Wide, Electronic Health Record–Based Medication Alerts for Appropriate Prescribing of Direct Oral Anticoagulants: Pilot Randomized Controlled Trial},
  journal = {JMIR Formative Research},
  year = {2024},
  doi = {10.2196/64674}
}
Kostenlos starten →